116 related articles for article (PubMed ID: 35723593)
21. Hyaluronic-Coated Albumin Nanoparticles for the Non-Invasive Delivery of Apatinib in Diabetic Retinopathy.
Radwan SE; El-Kamel A; Zaki EI; Burgalassi S; Zucchetti E; El-Moslemany RM
Int J Nanomedicine; 2021; 16():4481-4494. PubMed ID: 34239300
[TBL] [Abstract][Full Text] [Related]
22. Pigment epithelium-derived factor inhibits retinal microvascular dysfunction induced by 12/15-lipoxygenase-derived eicosanoids.
Ibrahim AS; Tawfik AM; Hussein KA; Elshafey S; Markand S; Rizk N; Duh EJ; Smith SB; Al-Shabrawey M
Biochim Biophys Acta; 2015 Mar; 1851(3):290-8. PubMed ID: 25562624
[TBL] [Abstract][Full Text] [Related]
23. A non-invasive nanoparticle mediated delivery of triamcinolone acetonide ameliorates diabetic retinopathy in rats.
Mahaling B; Srinivasarao DA; Raghu G; Kasam RK; Bhanuprakash Reddy G; Katti DS
Nanoscale; 2018 Sep; 10(35):16485-16498. PubMed ID: 29897081
[TBL] [Abstract][Full Text] [Related]
24. Shear sensitive injectable hydrogels of cross-linked tragacanthic acid for ocular drug delivery: Rheological and biological evaluation.
Chegini SP; Varshosaz J; Sadeghi HM; Dehghani A; Minaiyan M
Int J Biol Macromol; 2020 Dec; 165(Pt B):2789-2804. PubMed ID: 33736282
[TBL] [Abstract][Full Text] [Related]
25. Regulation of angiogenesis in diabetic retinopathy: possible balance between vascular endothelial growth factor and endostatin.
Noma H; Funatsu H; Yamashita H; Kitano S; Mishima HK; Hori S
Arch Ophthalmol; 2002 Aug; 120(8):1075-80. PubMed ID: 12149062
[TBL] [Abstract][Full Text] [Related]
26. Improved Melatonin Delivery by a Size-Controlled Polydopamine Nanoformulation Attenuates Preclinical Diabetic Retinopathy.
Sardoiwala MN; Nagpal S; Bhatt B; Roy Choudhury S; Karmakar S
Mol Pharm; 2023 Jun; 20(6):2899-2910. PubMed ID: 37116080
[TBL] [Abstract][Full Text] [Related]
27. Optical coherence tomography angiography analysis of macular vessel density before and after anti-VEGF therapy in eyes with diabetic retinopathy.
Sorour OA; Sabrosa AS; Yasin Alibhai A; Arya M; Ishibazawa A; Witkin AJ; Baumal CR; Duker JS; Waheed NK
Int Ophthalmol; 2019 Oct; 39(10):2361-2371. PubMed ID: 31119505
[TBL] [Abstract][Full Text] [Related]
28. Vascular endothelial growth factor-A
Ved N; Hulse RP; Bestall SM; Donaldson LF; Bainbridge JW; Bates DO
Clin Sci (Lond); 2017 Jun; 131(12):1225-1243. PubMed ID: 28341661
[TBL] [Abstract][Full Text] [Related]
29. Berberis dictyophylla F. inhibits angiogenesis and apoptosis of diabetic retinopathy via suppressing HIF-1α/VEGF/DLL-4/Notch-1 pathway.
Ai X; Yu P; Luo L; Sun J; Tao H; Wang X; Meng X
J Ethnopharmacol; 2022 Oct; 296():115453. PubMed ID: 35697191
[TBL] [Abstract][Full Text] [Related]
30. Investigation on the Q-markers of Bushen Huoxue Prescriptions for DR treatment based on chemometric methods and spectrum-effect relationship.
Yu Y; Zhu Z; Xie M; Deng L; Xie X; Zhang M
J Ethnopharmacol; 2022 Mar; 285():114800. PubMed ID: 34748867
[TBL] [Abstract][Full Text] [Related]
31. Vitreous levels of placental growth factor correlate with activity of proliferative diabetic retinopathy and are not influenced by bevacizumab treatment.
Al Kahtani E; Xu Z; Al Rashaed S; Wu L; Mahale A; Tian J; Abboud EB; Ghazi NG; Kozak I; Gupta V; Arevalo JF; Duh EJ
Eye (Lond); 2017 Apr; 31(4):529-536. PubMed ID: 27886182
[TBL] [Abstract][Full Text] [Related]
32. Retinoprotective effect of agmatine in streptozotocin-induced diabetic rat model: avenues for vascular and neuronal protection : Agmatine in diabetic retinopathy.
Abo El Gheit RE; Soliman NA; Badawi GA; Madi NM; El-Saka MH; Badr SM; Emam MN
J Physiol Biochem; 2021 May; 77(2):305-320. PubMed ID: 33635523
[TBL] [Abstract][Full Text] [Related]
33. Injectable gelatin derivative hydrogels with sustained vascular endothelial growth factor release for induced angiogenesis.
Li Z; Qu T; Ding C; Ma C; Sun H; Li S; Liu X
Acta Biomater; 2015 Feb; 13():88-100. PubMed ID: 25462840
[TBL] [Abstract][Full Text] [Related]
34. High-Mobility Group Box-1 Modulates the Expression of Inflammatory and Angiogenic Signaling Pathways in Diabetic Retina.
Abu El-Asrar AM; Mohammad G; Nawaz MI; Siddiquei MM
Curr Eye Res; 2015; 40(11):1141-52. PubMed ID: 25495026
[TBL] [Abstract][Full Text] [Related]
35. Fabrication of resveratrol coated gold nanoparticles and investigation of their effect on diabetic retinopathy in streptozotocin induced diabetic rats.
Dong Y; Wan G; Yan P; Qian C; Li F; Peng G
J Photochem Photobiol B; 2019 Jun; 195():51-57. PubMed ID: 31082734
[TBL] [Abstract][Full Text] [Related]
36. Cell recruiting chemokine-loaded sprayable gelatin hydrogel dressings for diabetic wound healing.
Yoon DS; Lee Y; Ryu HA; Jang Y; Lee KM; Choi Y; Choi WJ; Lee M; Park KM; Park KD; Lee JW
Acta Biomater; 2016 Jul; 38():59-68. PubMed ID: 27109762
[TBL] [Abstract][Full Text] [Related]
37. The ethanol extract of Zingiber zerumbet rhizomes mitigates vascular lesions in the diabetic retina.
Hong TY; Tzeng TF; Liou SS; Liu IM
Vascul Pharmacol; 2016 Jan; 76():18-27. PubMed ID: 26319672
[TBL] [Abstract][Full Text] [Related]
38. The role of CTGF in the diabetic rat retina and its relationship with VEGF and TGF-β(2) , elucidated by treatment with CTGFsiRNA.
Yang H; Huang Y; Chen X; Liu J; Lu Y; Bu L; Xia L; Xiao W; Chen M; Nie Q; Liu Z
Acta Ophthalmol; 2010 Sep; 88(6):652-9. PubMed ID: 20039857
[TBL] [Abstract][Full Text] [Related]
39. miR-142-5p regulates the progression of diabetic retinopathy by targeting IGF1.
Liu X; Li J; Li X
Int J Immunopathol Pharmacol; 2020; 34():2058738420909041. PubMed ID: 32116075
[TBL] [Abstract][Full Text] [Related]
40. Bone morphogenetic protein 2: a potential new player in the pathogenesis of diabetic retinopathy.
Hussein KA; Choksi K; Akeel S; Ahmad S; Megyerdi S; El-Sherbiny M; Nawaz M; Abu El-Asrar A; Al-Shabrawey M
Exp Eye Res; 2014 Aug; 125():79-88. PubMed ID: 24910902
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
